UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous infusion of coagulation factor concentrates during intensive treatment

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.24-32

2018

Volltextzugriff (PDF)

Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (4), p.544-549

2012

Volltextzugriff (PDF)

The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.e180-e187

2017

Volltextzugriff (PDF)

Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies

Haemophilia : the official journal of the World Federation of Hemophilia, 2005-09, Vol.11 (5), p.510-515

2005

Volltextzugriff (PDF)

Catheter‐directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short‐term patency

Journal of thrombosis and haemostasis, 2009-08, Vol.7 (8), p.1268-1275

2009

Volltextzugriff (PDF)

Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis

Arteriosclerosis, thrombosis, and vascular biology, 1997-04, Vol.17 (4), p.646-653

1997

Volltextzugriff (PDF)

Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly?

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-11, Vol.21 (6), p.709-714

2015

Volltextzugriff (PDF)

Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-11, Vol.22 (6), p.912-918

2016

Volltextzugriff (PDF)

No difference in quality of life between persons with severe haemophilia A and B

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-07, Vol.29 (4), p.987-996

2023

Volltextzugriff (PDF)

Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.589-597

2015

Volltextzugriff (PDF)

Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-03, Vol.22 (2), p.248-255

2016

Volltextzugriff (PDF)

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-09, Vol.16 (5), p.747-766

2010

Volltextzugriff (PDF)

Factor IX antibodies and tolerance in hemophilia B in the Nordic countries – The impact of F9 variants and complications

Thrombosis research, 2022-09, Vol.217, p.22-32

2022

Volltextzugriff (PDF)

How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.e406-e416

2016

Volltextzugriff (PDF)

Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (3), p.369-375

2014

Volltextzugriff (PDF)

PB2313: DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN‐IN (THE DART STUDY)

HemaSphere, 2022-06, Vol.6 (Suppl), p.2182-2183

2022

Volltextzugriff (PDF)

Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-01, Vol.20 (1), p.141-146

2014

Volltextzugriff (PDF)

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

The Lancet (British edition), 2012, Vol.379 (9810), p.31-38

2012

Volltextzugriff (PDF)

rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.764-770

2011

Volltextzugriff (PDF)

Recurrent venous thrombosis, post‐thrombotic syndrome and quality of life after catheter‐directed thrombolysis in severe proximal deep vein thrombosis

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1261-1263

2011

Volltextzugriff (PDF)

Southern African Landscapes and Environmental Change

1st, 2018

Volltextzugriff (PDF)

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial

The Lancet. Haematology, 2016-02, Vol.3 (2), p.e64-e71

2016

Volltextzugriff (PDF)

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.727-732

2009

Volltextzugriff (PDF)

Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting

Thrombosis and haemostasis, 1994-11, Vol.72 (5), p.666-671

1994

Volltextzugriff (PDF)

Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets

Thrombosis and haemostasis, 1998-02, Vol.79 (2), p.389-394

1998

Volltextzugriff (PDF)

1 – 25 von 1.414

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.214)
Mit Volltextzugriff
(1.074)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Continuous infusion of coagulation factor concentrates during intensive treatment

Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience

The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register

Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies

Catheter‐directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short‐term patency

Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis

Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly?

Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study

No difference in quality of life between persons with severe haemophilia A and B

Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey

Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Factor IX antibodies and tolerance in hemophilia B in the Nordic countries – The impact of F9 variants and complications

How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population

Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors

PB2313: DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN‐IN (THE DART STUDY)

Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency

Recurrent venous thrombosis, post‐thrombotic syndrome and quality of life after catheter‐directed thrombolysis in severe proximal deep vein thrombosis

Southern African Landscapes and Environmental Change

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience

Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting

Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets

Suchergebnisse filtern